Globus Medical Inc vs Eli Lilly & Co.
GMED vs LLY — side-by-side comparison from reported financials. GMED leads 4, LLY leads 6 of 10 comparable metrics.
Globus Medical Inc
GMED · Healthcare
$74.10+1.05%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | GMED | LLY |
|---|---|---|
| Price | $74.10 | $1 177.20 |
| Market cap | $9.95B | $1.05T |
| Revenue (TTM) | $3.14B | $79.7B |
| Revenue growth | +42.2% | +31.7% |
| Net margin | 17.0% | 33.5% |
| Free cash flow | $756M | $18.2B |
| Net cash (debt) | — | ($35.2B) |
| 1-year price return | +24.3% | +37.6% |
| P/E | 18.7 | 41.6 |
| P/E vs own history (cheap-side %) | 98% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 12% | 93% |
| Altman Z-score | 9.56 | 7.10 |
| CV checks passed | 9 of 10 | 11 of 10 |
| Employees | 6,000 | 50,000 |
Full résumé-style profiles: GMED CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.